1. Ye Y, Liu X, Wu N, Han Y, Wang J, Yu Y, Chen Q. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Frontiers in pharmacology. 2021;26(12):653887. [
DOI:10.3389/fphar.2021.653887] [
PMID] [
PMCID]
2. Wang H, Zhang H, Gao Z, Zhang Q, Gu C. The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Frontiers in cellular and infection microbiology. 2022; 25(12):854885. [
DOI:10.3389/fcimb.2022.854885] [
PMID] [
PMCID]
3. Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan ST, Šmejkal K, Malaník M, Sychrová A. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923. [
DOI:10.7150/thno.30787] [
PMID] [
PMCID]
4. Chang W, Chen L, Hatch GM. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochemistry and cell biology. 2015;93(5):479-86. [
DOI:10.1139/bcb-2014-0107] [
PMID]
5. Gasmi A, Asghar F, Zafar S, Oliinyk P, Khavrona O, Lysiuk R, Peana M, Piscopo S, Antonyak H, Pen JJ, Lozynska I. Berberine: Pharmacological features in health, disease and aging. Current Medicinal Chemistry. 2024;31(10):1214-34. [
DOI:10.2174/0929867330666230207112539] [
PMID]
6. Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani AS, Khan I. Berberine as a potential anticancer agent: A comprehensive review. Molecules. 2021;26(23):7368. [
DOI:10.3390/molecules26237368] [
PMID] [
PMCID]
7. Caliceti C, Franco P, Spinozzi S, Roda A, FG Cicero A. Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Current Medicinal Chemistry. 2016 ;23(14):1460-76.. [
DOI:10.2174/0929867323666160411143314] [
PMID]
8. Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H, Qiao L, Xie P. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis. Frontiers in Pharmacology. 2024;14:1287750. [
DOI:10.3389/fphar.2023.1287750] [
PMID] [
PMCID]
9. García-Muñoz AM, Victoria-Montesinos D, Ballester P, Cerdá B, Zafrilla P. A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin. Molecules. 2024;29(19):4576. [
DOI:10.3390/molecules29194576] [
PMID] [
PMCID]